A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PCOS

Search Conditions:
Search Keyword : PCOS
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: PCOS
Appearance Frequency: 8827 time(s)
Long forms: 35

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
polycystic ovary syndrome
(8767 times)
Endocrinology
(2508 times)
BMI (1085 times)
IR (469 times)
LH (446 times)
0 [Clinical implications of polycystic ovary syndrome].
PCOS group
(13 times)
Obstetrics
(4 times)
FSH (4 times)
LH (4 times)
BMI (2 times)
1997 17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss.
Prostate Cancer Outcomes Study
(5 times)
Urology
(3 times)
CI (3 times)
CEASAR (1 time)
OR (1 time)
2000 Validation study of retrospective recall of disease-targeted function: results from the prostate cancer outcomes study.
polycystic ovarian disease
(4 times)
Reproductive Medicine
(3 times)
AMPK (1 time)
CC (1 time)
CIHR (1 time)
1987 Pure FSH induces ovulation in polycystic ovary syndrome despite rising androgen levels.
PCO syndrome
(3 times)
Endocrinology
(2 times)
PCO (2 times)
AD (1 time)
EGF (1 time)
1990 Follicular fluid concentrations of insulin-like growth factor 1, epidermal growth factor, transforming growth factor-alpha and sex-steroids in volume matched normal and polycystic human follicles.
polycystic ovary disease
(3 times)
Endocrinology
(1 time)
AN (1 time)
cp (1 time)
MetS (1 time)
2002 Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome.
Prostate Cancer Care and Outcomes Study
(3 times)
Science
(2 times)
ADT (1 time)
CAMs (1 time)
HRQoL (1 time)
2011 Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study.
polycystic ovarian syndrome history
(2 times)
Metabolism
(1 time)
miRNAs (1 time)
2006 Incidence of acneform reactions after laser hair removal.
IV-polycystic ovariorum syndrome
(1 time)
Gynecology
(1 time)
ACA (1 time)
aPL (1 time)
APTT (1 time)
2000 [Antiphospholipid autoantibodies in women treated for infertility].
10  palliative care order set
(1 time)
Health Services
(1 time)
CMO (1 time)
2011 Impact of standardized palliative care order set on end-of-life care in a community teaching hospital.
11  parameters were comparable between Fathers
(1 time)
Endocrinology
(1 time)
BMI (1 time)
FGI (1 time)
FI (1 time)
2003 Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
12  Patient-Centered Outcomes Spectrum
(1 time)
General Surgery
(1 time)
EGS (1 time)
2018 Patient-Centered Outcome Spectrum: An Evidence-based Framework to Aid in Shared Decision-making.
13  patients about their condition
(1 time)
Public Health
(1 time)
--- 2008 Implementation of dietary and general lifestyle advice among women with polycystic ovarian syndrome.
14  patients with micropolycystic ovary syndrome
(1 time)
Endocrinology
(1 time)
--- 1988 Episodic pulsatile secretion of FSH, LH, prolactin, oestradiol, oestrone, and LH circadian variations in polycystic ovary syndrome.
15  PCO rats
(1 time)
Endocrinology
(1 time)
PCO-SON rats (1 time)
SON (1 time)
2018 Sympathetic innervation regulates macrophage activity in rats with polycystic ovary.
16  PCOS compared to controls
(1 time)
Endocrinology
(1 time)
FMD (1 time)
IMT (1 time)
NID (1 time)
2006 Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
17  PCOS group, PCOSG
(1 time)
Gynecology
(1 time)
QOL (1 time)
RET (1 time)
2016 Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training.
18  PCOS only
(1 time)
Internal Medicine
(1 time)
FMD (1 time)
2017 Association between polycystic ovary syndrome and the risk of subclinical vascular disease in normal‑weight women with type 1 diabetes.
19  PCOS women
(1 time)
Endocrinology
(1 time)
FMD (1 time)
IMT (1 time)
NID (1 time)
2006 Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic ovary syndrome.
20  PCOS-Anov
(1 time)
Endocrinology
(1 time)
AGEs (1 time)
AMH (1 time)
Non-PCOS Anov (1 time)
2009 Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.
21  PCOS-d
(1 time)
Endocrinology
(1 time)
--- 2016 Evidence for Increased 5alpha-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome.
22  PCOS-SNPs
(1 time)
Reproductive Medicine
(1 time)
C9orf3 (1 time)
DENND1A (1 time)
GWAS (1 time)
2015 Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
23  PCOSEs
(1 time)
Reproductive Medicine
(1 time)
SHBG (1 time)
2007 Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome.
24  pellets containing DHT
(1 time)
Endocrinology
(1 time)
DHT (1 time)
EA (1 time)
GLUT4 (1 time)
2010 Intense electroacupuncture normalizes insulin sensitivity, increases muscle GLUT4 content, and improves lipid profile in a rat model of polycystic ovary syndrome.
25  physiopathological condition
(1 time)
Medicine
(1 time)
IR (1 time)
LEP (1 time)
2003 [Leptin in patients with polycystic ovary syndrome. Direct correlation with insulin resistance].
26  PLGA-coated-only stents
(1 time)
Cardiology
(1 time)
BMS (1 time)
PCSES (1 time)
PLGA (1 time)
2009 Long-term effects of novel biodegradable, polymer-coated, sirolimus-eluting stents on neointimal formation in a porcine coronary model.
27  polycystic ovarian disease syndrome
(1 time)
Genetics
(1 time)
POI (1 time)
2013 Gene bionetworks that regulate ovarian primordial follicle assembly.
28  polycystic ovary syndrome patients
(1 time)
Gynecology
(1 time)
FIN (1 time)
FPG (1 time)
HOMA (1 time)
2006 [Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance].
29  Polycystic Ovary Syndrome women
(1 time)
Biochemistry
(1 time)
OAT (1 time)
OATP (1 time)
WB (1 time)
2015 Expression of steroid sulfated transporters and 3beta-HSD activity in endometrium of women having polycystic ovary syndrome.
30  Polycystic syndrome
(1 time)
Gynecology
(1 time)
--- 2012 Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.
31  potential (CCL2, IL-6, ORM1, TNAIFP6, SFRP4, SPARC). eSF
(1 time)
Endocrinology
(1 time)
eEPs (1 time)
eSFs (1 time)
2013 Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
32  prooncogenic changes, independent of body mass index, especially in eEP
(1 time)
Endocrinology
(1 time)
eEPs (1 time)
eSFs (1 time)
2013 Mesenchymal stem/progenitors and other endometrial cell types from women with polycystic ovary syndrome (PCOS) display inflammatory and oncogenic potential.
33  Prospective study of age-matched, nonpolycystic ovary syndrome
(1 time)
Infertility
(1 time)
DHEAS (1 time)
FF (1 time)
IVF (1 time)
2015 Follicular fluid dehydroepiandrosterone sulfate is a credible marker of oocyte maturity and pregnancy outcome in conventional in vitro fertilization cycles.
34  purified COS products
(1 time)
Carbohydrates
(1 time)
COS (1 time)
DP (1 time)
HLP (1 time)
2017 Enzymatic single-step preparation and antioxidant activity of hetero-chitooligosaccharides using non-pretreated housefly larvae powder.
35  registries-Prostate Cancer Outcomes Study
(1 time)
Neoplasms
(1 time)
CaPSURE (1 time)
CPDR (1 time)
PSA (1 time)
2004 Prostate cancer 2004: insights from national disease registries.